Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Total 13F shares
-
111,129
-
Share change
-
+62,470
-
Total reported value
-
$10,668,334
-
Put/Call ratio
-
191%
-
Price per share
-
$96.00
-
Number of holders
-
13
-
Value change
-
+$5,851,533
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q1 2023
As of 31 Mar 2023,
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
111,129 shares.
The largest 10 holders included
SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), Traynor Capital Management, Inc., GOLDMAN SACHS GROUP INC, Capital Investment Advisors, LLC, Cutler Group LLC / CA, MORGAN STANLEY, Kelly Financial Services LLC, and Bartlett & Co. LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.